Trial
NCT01355562
Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Loma Linda University
Collaborators
—
Condition
Melanoma
Intervention
Interleukin-2 (IL-2)
Why stopped
Primary Investigator is no longer employed at LLU as of 02/29/12.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-30